Core Points - The Hong Kong Stock Connect Innovative Drug ETF (159570) experienced a decline of 1.07% on September 19, with a trading volume of 2.005 billion yuan [1] - The fund's shares increased by 11 million to a total of 11.056 billion shares, with a total increase of 2.654 billion shares over the past 20 trading days [1] - The latest net asset value of the fund is 21.494 billion yuan [1] - The performance benchmark for the ETF is the National Index of Hong Kong Stock Connect Innovative Drugs, adjusted for valuation exchange rates [1] - The fund is managed by E Fund Management Co., Ltd., with the fund manager being Le Wuqiong [1] - Since its establishment on December 28, 2023, the fund has achieved a return of 94.42%, while the return over the past month is -3.68% [1]
9月19日港股通创新药ETF（159570）份额增加1100.00万份
Xin Lang Cai Jing·2025-09-22 01:11